Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 4 , Pages 595-601 , April 2008

Treatment Disparities for Disabled Medicare Beneficiaries With Stage I Non-Small Cell Lung Cancer

  • Lisa I. Iezzoni, MD

      Affiliations

    • Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA
    • Institute for Health Policy, Massachusetts General Hospital, Boston, MA
    • Corresponding Author InformationReprint requests to Lisa I. Iezzoni, MD, Institute for Health Policy, Massachusetts General Hospital, 50 Staniford St, Rm 901, Boston, MA 02114
    • ,
  • Long H. Ngo, PhD

      Affiliations

    • Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA
    • ,
  • Donglin Li, MD

      Affiliations

    • Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA
    • ,
  • Richard G. Roetzheim, MD

      Affiliations

    • Department of Family Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
    • ,
  • Reed E. Drews, MD

      Affiliations

    • Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA
    • ,
  • Ellen P. McCarthy, PhD

      Affiliations

    • Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA

References 

  1. Ries LA, Harkins D, Krapcho M, et al. SEER cancer statistics review, 1975-2003. Bethesda: National Cancer Institute; 2005;Nov http://seer.cancer.gov/csr/1975_2003/Accessed February 18, 2007
  2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (Non-Small Cell Lung Cancer. v.2. 2006). http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdfAccessed November 13, 2006
  3. Manser R, Wright G, Hart D, Byrnes G, Campbell D. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev. 2005;(1):CD004699
  4. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198–1205
  5. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006;24:413–418
  6. Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998;36:1337–1348
  7. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128:729–736
  8. Shavers VL, Brown ML, Potosky AL, et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med. 2004;19:146–155
  9. Steyerberg EW, Earle CC, Neville BA, Weeks JC. Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2005;20:510–517
  10. U.S. Department of Health and Human Services. Healthy people 2010 (With understanding and improving health and objectives for improving health). In: 2nd ed.. With understanding and improving health and objectives for improving health. Vols 1, 2:Washington (DC): U.S. Government Printing Office; 2000;Nov
  11. U.S. Department of Health and Human Services, Office of the Surgeon General. The Surgeon General’s call to action to improve the health and wellness of persons with disabilities. Washington (DC): U.S. Department of Health and Human Services, Office of the Surgeon General; 2005;July
  12. McCarthy EP, Ngo LH, Roetzheim RG, et al. Disparities in breast cancer treatment and survival for women with disabilities. Ann Intern Med. 2006;145:637–645
  13. Iezzoni LI, O’Day BL. More than ramps (A guide to improving health care quality and access for people with disabilities). New York: Oxford Univ Pr; 2006;
  14. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of SEER-Medicare data: content, applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):3–18
  15. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31:732–748
  16. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(8 Suppl):IV43–IV48
  17. Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care. 2002;40(8 Suppl):IV49–IV54
  18. Surveillance, Epidemiology, and End Results (SEER) Program. Public-use data (1973-2001). Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2004;Apr
  19. Social Security Administration. Annual statistical supplement. 2003;www.ssa.gov/policy/docs/statcomps/supplement/2003/6c.html#table6.c3Accessed October 31, 2006
  20. McCarthy EP, Ngo L, Chirikos T, et al. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare. Health Serv Res. 2007;42:611–628
  21. Riley GF. The cost of eliminating the 24-month Medicare waiting period for Social Security disabled-worker beneficiaries. Med Care. 2004;42:387–394
  22. Riley GF, Lubitz JD, Zhang N. Patterns of health care and disability for Medicare beneficiaries under 65. Inquiry. 2003;40:71–83
  23. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit or declining surgery (medically inoperable): a systematic review. Cochrane Database Syst Rev. 2001;(2):CD002935
  24. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351–360
  25. Flanders WD, Rhodes PH. Large sample confidence intervals for regression standardized risks, risk ratios, and risk differences. J Chronic Dis. 1987;40:697–704
  26. Beckles MA, Spiro SG, Colice GL, Rudd RM. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest. 2003;123:105–114
  27. Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry. 2004;161:2317–2319
  28. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192:421–427
  29. Casey DE. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am J Med. 2005;118(Suppl 2):15S–22S
  30. Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003;326:223–230
  31. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:1107–1115
  32. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. Are mood disorders and obesity related? (A review for the mental health professional). J Clin Psychiatry. 2004;65:634–651
  33. Susce MT, Villanueva N, Diaz FJ, de Leon J. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry. 2005;66:167–173
  34. Drake RE, Wallach MA, Alverson HS, Mueser KT. Psychosocial aspects of substance abuse by clients with severe mental illness. J Nerv Ment Dis. 2002;190:100–106
  35. Xie H, McHugo GJ, Fox MB, Drake RE. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatr Serv. 2005;56:1282–1287
  36. MCBS Project. Health & health care of the Medicare population: data from the 2003 Medicare Current Beneficiary Survey. Rockville: Westat; 2006;
  37. López-Encuentra A, García-Luján R, Rivas JJ, et al. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg. 2005;79:974–979
  38. Committee on the Consequences of Uninsurance, Institute of Medicine. Coverage matters (Insurance and health care). In: Washington (DC): Natl Acad Pr; 2001;p. 22
  39. Committee on the Consequences of Uninsurance, Institute of Medicine. Care without coverage (Too little, too late). In: Washington (DC): Natl Acad Pr; 2002;p. 4
  40. Morris J. Pride against prejudice (Transforming attitudes to disability). London: The Women’s Pr; 1996;
  41. Gerhart KA, Koziol-McLain J, Lowenstein SR, Whiteneck GG. Quality of life following spinal cord injury: knowledge and attitudes of emergency care providers. Ann Emerg Med. 1994;23:807–812
  42. Basnett I. Health care professionals and their attitudes toward and decisions affecting disabled people. In:  Albrecht GL,  Seelman KD,  Bury M editor. Handbook of disability studies. Thousands Oaks: Sage; 2001;p. 450–467
  43. Olkin R. What psychotherapists should know about disability. New York: Guildford Pr; 1999;
  44. Iezzoni LI. Going beyond disease to address disability. N Engl J Med. 2006;355:976–979
  45. Iezzoni LI, Davis RB, Soukup J, O’Day B. Quality dimensions that most concern people with physical and sensory disabilities. Arch Intern Med. 2003;163:2085–2092

 Supported by the National Cancer Institute (grant no. R01 CA100029).

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

PII: S0003-9993(07)01852-7

doi: 10.1016/j.apmr.2007.09.042

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 4 , Pages 595-601 , April 2008

Article Tools